Genentech presents new giredestrant breast cancer data at ASCO 2026
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), will present data from nine approved and investigational ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
